The premises and/or the manufacturing process were inadequate for minimizing contamination of the drugs and/or materials during fabrication and/or packaging. The temperature and/or humidity control was inadequate.
Inspection Record
Catalent Ontario Limited — Health Canada Inspection Findings
View the regulator's official source The source document is always the basis for judgement.
Findings
Evaluation of production processes, equipment, and/or materials was inadequate.
Investigations into deviations, reports, and/or follow-up actions were inadequate.
The recorded information or details were inadequate.
The creation, maintenance, processing, and/or review of laboratory data was inadequate.
Validation studies were not conducted in keeping with the predefined protocols.
The quality control department did not appropriately approve, assess, and/or document the reprocessing and/or reworking of a lot and/or batch.
Water treatment plants and distribution systems were not designed, constructed, or maintained to ensure a reliable and adequate source of water. The preventative maintenance and repair of the equipment was inadequate.
About this record
Extracted automatically from the document of the Health Canada inspection on 2022-03-22. The source is available at the link above.
This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.
Translation and classification are automated and may differ in nuance from the source.
